National Bank of Canada Reduces $6M in Cardinal Health, Inc. ($CAH)
Key Points
- National Bank of Canada changed its Cardinal Health, Inc. ($CAH) stake by 6.6% last quarter, cutting to 405,191 shares worth $89.61 million.
- Wall Street's consensus rating on $CAH is Strong Buy and an average price target of $245.27.
- $CAH last traded around $221.16.
National Bank of Canada trimmed its position in Cardinal Health, Inc. ($CAH) by 6.6% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 405,191 shares of Cardinal Health, Inc. after selling 28,607 shares during the quarter. National Bank of Canada's holdings in Cardinal Health, Inc. were worth $89.61 million as of its most recent filing.
Cardinal Health, Inc. ($CAH) Stock
Cardinal Health, Inc. Earnings
Cardinal Health, Inc. Dividend
Analysts Set New Price Targets
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.